Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Fortress Biotech, Inc. (FBIO)
- Corbus Pharmaceuticals Holdings, Inc. CRBP 3.05 +6.64%
- Fortress Biotech, Inc. FBIO 1.85 +0.54%
Corbus Pharmaceuticals Holdings, Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Fortress Biotech, Inc. is the larger, with a market value of $61.4M against $55.3M — 1.1× the size. Corbus Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −73.7%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 19 metrics below, Fortress Biotech, Inc. leads on 13 and Corbus Pharmaceuticals Holdings, Inc. on 6.
Valuation
Profitability
| Metric | CRBP | FBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 65.59% | 68.51% |
| Operating margin | 0.00% | (42.61%) | 0.00% |
| Net margin | 0.00% | 150.98% | 0.00% |
| Free cash flow margin | 0.00% | 183.80% | 0.00% |
| Return on equity | (95.58%) | 84.91% | (51.96%) |
| Return on assets | (80.85%) | 43.38% | (46.06%) |
| Return on invested capital | 0.00% | (41.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack